Professional Experience
Dr. Meldgaard has a long and distinguished career in oncology, balancing clinical practice, leadership, and academic contributions.
- Current Position: Chief Physician, Department of Oncology, Aarhus University Hospital (Since 2008)
- Previous Roles:
- Consultant, Department of Oncology, Aarhus University Hospital
- Clinical Associate Professor, Department of Clinical Medicine, Aarhus University
- Leadership Roles: Mentorship and supervision of oncology staff and trainees
Academic Contributions
Dr. Meldgaard has significantly contributed to oncology research and education through publications, teaching, and conference presentations.
- Research Interests: Lung cancer, cancer biomarkers, next-generation sequencing, circulating tumor DNA (ctDNA)
- Teaching Positions: Clinical lecturer at Aarhus University
- Publications: Over 160 peer-reviewed articles on oncology and lung cancer
- Conferences & Training: Speaker at international oncology conferences and workshops
Areas of Expertise
Dr. Meldgaard specializes in lung cancer and related conditions, using advanced diagnostic and therapeutic techniques to deliver personalized patient care.
- Conditions Treated: Non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC)
- Diagnostic Techniques: Next-generation sequencing, ctDNA analysis, advanced imaging
- Patient-Centric Approach: Development of personalized treatment plans
Publications and Research
Dr. Meldgaard has authored influential research studies on lung cancer, contributing to advancements in clinical practice and patient care.
- Selected Publications:
- Ulhøi MP, Meldgaard P. “Navigating treatment sequencing in ALK-positive NSCLC: lorlatinib as a key to prolonged survival?” Transl Lung Cancer Res. 2025 Jul;14(7):2359-2363.
- Meldgaard P, et al. “Improved overall survival for Stage III NSCLC patients with concurrent chemoradiotherapy: A retrospective cohort study.” Acta Oncol. 2023;62(2):245-252.
- Greibe E, Meldgaard P, et al. “Validation of an LC-MS/MS method for Osimertinib quantification in plasma for patient monitoring.” J Chromatogr B. 2022.
- Research Platforms: Profiles available on PubMed, ResearchGate, and ORCID
Patient Care Philosophy
Dr. Meldgaard emphasizes ethical, empathetic, and transparent patient care, ensuring patients are fully informed and supported throughout treatment.
- Communication: Clear explanation of diagnosis and treatment options
- Ethics: Focus on equal access to treatment and avoiding inequity
- International Patients: Consultation and guidance available for global patients
- Patient Satisfaction: Commitment to supportive care and quality of life
Professional Affiliations
Dr. Meldgaard holds memberships in prominent national and international oncology organizations, reflecting his professional recognition and leadership.
- National Memberships: Danish Society for Clinical Oncology
- International Memberships: European Society for Medical Oncology (ESMO)
- Certifications: Board-certified in oncology by the Danish Medical Association
FAQs
- Is Dr. Peter Meldgaard board-certified?
- Yes, he is board-certified in oncology by the Danish Medical Association.
- What types of surgeries does he perform?
- He specializes in surgical procedures for lung cancer, including resections and minimally invasive surgeries.
- Does he treat international patients?
- Yes, he offers consultation and guidance for patients from abroad seeking expert oncology care.
- How long is the typical hospital stay?
- Hospital stays vary based on treatment complexity, ranging from a few days to several weeks.
- What languages does he speak?
- Dr. Meldgaard is fluent in Danish and English, allowing him to serve a diverse patient population.
- What is his approach to patient care?
- He emphasizes empathy, clear communication, and ethical, patient-centered care.
- What research areas does he focus on?
- Lung cancer, cancer biomarkers, next-generation sequencing, and circulating tumor DNA (ctDNA) for treatment monitoring.
